Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Eur J Med Chem
2014 Oct 06;85:517-25. doi: 10.1016/j.ejmech.2014.08.022.
Show Gene links
Show Anatomy links
Heck products of parthenolide and melampomagnolide-B as anticancer modulators that modify cell cycle progression.
Penthala NR
,
Bommagani S
,
Janganati V
,
MacNicol KB
,
Cragle CE
,
Madadi NR
,
Hardy LL
,
MacNicol AM
,
Crooks PA
.
???displayArticle.abstract???
(E)-13-(Aryl/heteroaryl)parthenolides (5a-i and 6a-i) were synthesized and evaluated for their ability to modify cell cycle progression during progesterone-stimulated Xenopus oocyte maturation and screened for their anticancer activity against a panel of 60 human cancer cell lines. (E)-13-(4-aminophenyl) parthenolide (5b) caused a significant inhibition of progesterone-stimulated oocyte maturation, and was determined to function downstream of MAP kinase signaling, but upstream of the activation of the universal G2/M regulator, M-phase promoting factor (MPF), cyclin B/Cyclin-dependent kinase (CDK). The compound (E)-13-(2-bromo-phenyl)parthenolide (5c) activates oocyte maturation independently of progesterone stimulation. Compounds 5b and 5c displayed modest growth inhibition on select cancer cell lines at 10 μM dose when tested on the panel of 60 cancer cell lines. By contrast, compounds (5f and 7) did not modulate oocyte maturation but did exhibit micromolar level growth inhibition against most of the human cancer cell lines over a range of doses. Together, our findings indicate that screening of compounds in the oocyte maturation assay may identify additional effective cell cycle regulatory compounds that do not necessarily exert overt cytotoxicity as assessed in traditional drug screening assays.
???displayArticle.pubmedLink???
25117652
???displayArticle.pmcLink???PMC4167622 ???displayArticle.link???Eur J Med Chem ???displayArticle.grants???[+]
Cragle,
Musashi protein-directed translational activation of target mRNAs is mediated by the poly(A) polymerase, germ line development defective-2.
2014, Pubmed,
Xenbase
Cragle,
Musashi protein-directed translational activation of target mRNAs is mediated by the poly(A) polymerase, germ line development defective-2.
2014,
Pubmed
,
Xenbase
Dell'Agli,
Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives.
2009,
Pubmed
Gopal,
Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated.
2007,
Pubmed
Guzman,
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
2005,
Pubmed
Guzman,
Feverfew: weeding out the root of leukaemia.
2005,
Pubmed
Hall,
Anti-inflammatory activity of sesquiterpene lactones and related compounds.
1979,
Pubmed
Han,
Semisynthetic derivatives of sesquiterpene lactones by palladium-catalyzed arylation of the alpha-methylene-gamma-lactone substructure.
2009,
Pubmed
Hanson,
Inhibition of phosphofructokinase by quinone methide and alpha-methylene lactone tumor inhibitors.
1970,
Pubmed
Hehner,
Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta.
1998,
Pubmed
Heptinstall,
Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups.
1988,
Pubmed
Howard,
The mitogen-activated protein kinase signaling pathway stimulates mos mRNA cytoplasmic polyadenylation during Xenopus oocyte maturation.
1999,
Pubmed
,
Xenbase
Hwang,
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system.
2006,
Pubmed
Janganati,
Heterocyclic aminoparthenolide derivatives modulate G(2)-M cell cycle progression during Xenopus oocyte maturation.
2014,
Pubmed
,
Xenbase
Kim,
Resistance of cholangiocarcinoma cells to parthenolide-induced apoptosis by the excretory-secretory products of Clonorchis sinensis.
2009,
Pubmed
Kupchan,
Reactions of alpha methylene lactone tumor inhibitors with model biological nucelophiles.
1970,
Pubmed
Kupchan,
Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones.
1971,
Pubmed
Lasko,
Translational control during early development.
2009,
Pubmed
,
Xenbase
López-Franco,
Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis.
2006,
Pubmed
Machaca,
Induction of maturation-promoting factor during Xenopus oocyte maturation uncouples Ca(2+) store depletion from store-operated Ca(2+) entry.
2002,
Pubmed
,
Xenbase
MacNicol,
Developmental timing of mRNA translation--integration of distinct regulatory elements.
2010,
Pubmed
,
Xenbase
Marin,
Apoptosis induced by Magnolia Grandiflora extract in chlorambucil-resistant B-chronic lymphocytic leukemia cells.
2010,
Pubmed
Nasim,
Melampomagnolide B: a new antileukemic sesquiterpene.
2011,
Pubmed
Nasim,
Antileukemic activity of aminoparthenolide analogs.
2008,
Pubmed
Neelakantan,
Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).
2009,
Pubmed
Oka,
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
2007,
Pubmed
Patel,
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
2000,
Pubmed
Penthala,
(E)-13-(4-Amino-phen-yl)parthenolide.
2013,
Pubmed
Pfaffenrath,
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
2002,
Pubmed
Ralstin,
Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
2006,
Pubmed
Riganti,
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.
2009,
Pubmed
Sun,
The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.
2007,
Pubmed
Sweeney,
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer.
2005,
Pubmed
Wen,
Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide.
2002,
Pubmed
Won,
Parthenolide sensitizes ultraviolet (UV)-B-induced apoptosis via protein kinase C-dependent pathways.
2005,
Pubmed